Recently the concept of using specific inhibitors of endogenous cholesterol synthesis as a means of reducing the cholesterol content of the body has been reviewed (1). One such specific inhibitor is the metal vanadium. Salts of vanadium have been shown to inhibit the utilization of mevalonic acid for cholesterol biosynthesis (2), to inhibit cholesterol biosynthesis in vitro and in vivo (3), to induce mobilization of predeposited aortic cholesterol in rabbits (4) and to lessen the deposition of cholesterol in rabbits (5) and in birds (6) fed high cholesterol diets.
Recently the concept of using specific inhibitors of endogenous cholesterol synthesis as a means of reducing the cholesterol content of the body has been reviewed (1) . One such specific inhibitor is the metal vanadium. Salts of vanadium have been shown to inhibit the utilization of mevalonic acid for cholesterol biosynthesis (2) , to inhibit cholesterol biosynthesis in vitro and in vivo (3) , to induce mobilization of predeposited aortic cholesterol in rabbits (4) and to lessen the deposition of cholesterol in rabbits (5) and in birds (6) fed high cholesterol diets.
To extend these studies to man, the effects of vanadium on sterol balance in normocholesterolemic men under rigid dietary control were examined. The investigations reported here show that, under such conditions, inhibition of endogenous cholesterol biosynthesis with a salt of vanadium produces a lowering of serum cholesterol levels. The studies provide data which suggest that mobilization of tissue cholesterol stores also occurs.
MATERIAL AND METHODS
A. Experimental group. The subjects for the study were five normal male medical students, 23 to bedtime snack. The diet contained 109 Gm. of protein, 58 Gm. of fat and 321 Gm. of carbohydrate each day for a total of 2,242 calories. Two of the men, R. M. and E. W., received an additional 363 calories as bread and jelly to maintain their weight during the last three weeks of the study. All of the items in the diet with the exception of lettuce, tomatoes and bread were utilized from a single bulk lot purchased at the start of the experiment. Fat was supplied primarily from lean hamburger, butter, ice cream and bologna. Black coffee and tea were allowed as desired. One decavitamin tablet (U.S.P.) was given each day to obviate any possible change in available vitamins induced by modification of intestinal flora due to the vanadium. By careful weighing of portions and use of constant temperatures in cooking, variations in fat content were kept to a minimum. Weekly analyses of a total day's portion of food revealed variations of less than 2 per cent in fat and dietary sterol intake. C. Experimental design. The men ate an identical diet during the entire study. After a two week control period, each man received diammonium oxy-tartratovanadate1 (B. B., 100 mg.; others, 125 mg.) orally in three divided doses each day for the experimental period of six weeks. During the final recovery period of three weeks the vanadium administration was discontinued.
D. Chemical methods. Serum. Fasting blood samples were obtained once each week. Cholesterol (7), phospholipid (8, 9) , triglyceride (10), alkaline phosphatase (11) and transaminase (12) serum levels were determined. Serum cholesterol determinations were carried out on duplicate aliquots of sera.
Urine. Twenty-four hour samples were collected once each week and daily for the week after cessation of vanadium administration. Vanadium was determined by a colorimetric method (13) as well as spectrographically.2 17-Ketosteroids and 17,21-dihydroxy-20-ketosteroids were determined at the start and end of the period of vanadium administration (14, 15) . Routine (7) and total 3a and P-OH L.B. positive sterols (17) . Using this extraction procedure and triplicate samples of dried, powdered feces, these sterol procedures were found to give as good recoveries of sterol as is the case when serum is analyzed. Some difficulty was experienced with nonspecific chromagens with the Abell, Levy, Brodie and Kendall procedure (17) . For (19) . Total fat content was also determined on aliquots of the dried feces (20) .
Diet. Aliquots of the total 24 hour diet, prepared by homogenization in a Waring Blendor with water, were analyzed for total fat (20) and neutral sterol (7, 16, 17) content.
E. Statistics. A statistically significant difference in this paper is defined as a probability of <0.05 as calcu- Again referring to Figure 1 , it is seen that a change in the body sterol must represent the sum of the changes in the serum and tissue sterols: 5) AB = ASe + AT, where AT = change in tissue sterol content = tissue sterol content in vanadium period-tissue sterol content in recovery period = Tv -TR. ASe = change in total serum cholesterol = total serum cholesterol content in vanadium period-total serum cholesterol content in recovery period = Sev-SeR.
From the above equations, ADR, ADv, AFDR, AFDv, IR, Iv, ABv and ATv are calculated as shown in Addendum.
SR is obtained from Equation 4 by assuming that the steady state has again been reached and ABR is zero (see
Sv is obtained by assuming that the ratio Iv/IR is proportional to the ratio SV/SR (see Discussion).
All quantities are expressed as mg. of cholesterol per day.
RESULTS

Serum lipids
The results of serum determinations for total cholesterol, free cholesterol, phospholipid and triglyceride are given in Table I . In Figure 2 (24) , the C/P ratio is the most reliable indication of the atherogenicity of the serum lipids, then cholesterol synthesis inhibition has, in a period of six weeks, produced a beneficial change in this index.
It can be seen in Table I Table I the results of determinations done on the feces are tabulated. From the lack of change in the fat content (Column 10) it is clear that vanadium did not interfere with fat absorption from the gastrointestinal tract. In Figure  3 the mean 24 hour fecal content of the various sterol fractions and the bile acids are graphed separately and as total sterol excretion. The top curve shows the decline in total fecal sterol excretion (p < 0.05) during the period of vanadium administration and then the rise (p < 0.05) during the recovery phase after vanadium. The total L. B. positive sterols as determined by the Abell, Levy, Brodie and Kendall procedure (17) and the digitonin precipitable, L. B. negative sterols declined significantly during vanadium dosage but the decrease in the bile acids was not significant when considered separately.
Relation of absorbed vanadium to effects on sterol balance
It is known that urinary vanadium represents approximately 60 per cent of the vanadium absorbed from the gastrointestinal tract during the previous 24 hours (26) . Urinary vanadium levels as determined weekly by a dye method (13) showed a wide variation both from one week to the next for the same individual and from one subject to another on the same dosage of diammonium oxy-tartratovanadate. These values ranged from 4 to 100 A'g. V/L. urine. It soon became obvious that the absorption of vanadium from the gastrointestinal tract was most variable. However, at the conclusion of the vanadium administration period, total urine was collected for the next five days and analyzed for vanadium content Figure 4 the residual vanadium has been plotted against the per cent reduction in the serum free cholesterol for each of the men in the study. It is clear that a relationship exists between the retained vanadium and the lowering of the serum free cholesterol. In Figure 5 , using the spectrographic data, we find a similar curve which suggests that a concentration of approximately 1 ,ug.
vanadium per pound body weight is necessary for a maximal effect.
Vanadium toxicity
There were no overt evidences of toxicity from vanadium in any of the men. Complete blood counts including platelets, routine urinalyses, blood urea nitrogen and blood glucose remained unchanged during the six weeks of vanadium administration. Liver functions as determined by serum cholesterol esters, serum alkaline phosphatase, serum transaminase and serum bilirubin were unchanged. The possibility existed that inhibition of cholesterol synthesis might also 3) the reduction in fecal sterol output is subject to a variety of interpretations.
In discussing the first of these points, it is clear that the reduction in serum cholesterol after six weeks of vanadium administration is small; the maximal reduction in free cholesterol is about 20 per cent. However, it must be noted that the subjects of this study were normocholesteremic young men with presumably normal rates of cholesterol synthesis and with normal plasma lipoprotein transport systems. Under such conditions it seems unwarranted to expect a marked change in serum cholesterol after a short period of inhibition of endogenous cholesterol synthesis.
The second point, concerning evidence for cholesterol synthesis inhibition, must be approached indirectly if one is to avoid the use of radioactive tracers in normal humans. Vanadium has been shown to inhibit cholesterol synthesis in animals by direct means (3, 4) . To It is impossible to choose between these alternatives on the basis of the data presented in the paper. However, it is possible to furnish indirect evidence which makes the first possibility most unlikely and to suggest a mathematical means of differentiating between the second and third alternatives.
Let us first consider the possibility that tissue sterol stores have actually increased during the period of vanadium administration with no change in cholesterol synthesis. The evidence that cholesterol synthesis is inhibited has been given. Mountain, Stockell and Stokinger found lowered tissue sterol stores after vanadium administration in normocholesteremic rabbits (5) . Such direct data for man are not available. However, suggestive evidence is provided by cholesterol analyses of livers from two patients with brain tumors who had received diammonium oxy-tartratovanadate for four and eight months, respectively. The liver cholesterol levels were 225 and 250 mg. per 100 Gm. of liver, values below the average normal of 300 mg. per 100 Gm. for a 70 Kg. man (28) .
To enable us to choose between the possibilities that tissue sterol stores have remained the same or decreased, we must discuss the validity of our balance methods and the procedure for calculating the tissue sterol stores from the balance data.
In order to evaluate the effect of a cholesterol synthesis inhibitor on sterol balance in man under rigid dietary control, it is necessary to measure the dietary sterol, the fecal neutral sterol and the fecal bile acids. Then, assuming the amounts of sterols lost by excretion in urine to be insignificant and those lost in sebum to be constant and knowing in this case that conversion to steroid hormones is unchanged, the sterol balance may be determined by the calculations given in the Methods. These calculations were devised as a means of separating the effect of a drug on the serum cholesterol level from its effect on the tissue sterol level. It has been apparent to clinicians for years that in any given patient the level of the serum cholesterol is a poor means of judging the degree of atherosclerosis. By the same token, perhaps we should be more reserved in using a fall in serum cholesterol after a particular type of therapy as an indication of a beneficial action. By analogy one is reminded of the frequent lack of correlation between serum and tissue potassium levels.
Validity of the calculations
The initial validity of the calculations depends on whether the lowering of total fecal sterol output after vanadium is due to increased destruction of sterol by the bacterial flora of the intestinal tract. To solve this problem, feces with and without added vanadium were incubated and then analyzed. No change in total fecal sterol content was found. Without the use of isotopes it was, of course, impossible to assay directly the amount of absorbed dietary sterol. By the method of Cook, Edwards and Riddell (21) the increment in sterol absorption over that existing in the control period is measured. Thus our calculated amounts of ADR and ADv are each too small by the quantity of dietary sterol absorbed in the control period. However, as can be seen from the example in the Addendum, even if this missing quantity were as high as 400 mg. (representing an unlikely 60 per cent absorption in the control period) the change in the Iv/IR ratio would be only 2 per cent. Also, any increase in AFDV would increase the significance of the negative change in AB.
To calculate the synthesis during the recovery period, it is necessary to assume that the steady state has again been reached and that ABR is zero. Because it is likely that, in the absence of a lowering of cholesterol endogenous synthesis, man is always storing some cholesterol, in actuality ABR is probably a very small positive number.
However, this constant storage of sterol must be so small on a daily basis that our assumption that it is zero should not influence the far larger changes found in sterol output.
Finally, to calculate the synthesis in the vanadium periods, it is necessary to assume that the ratio Iv/IR is proportional to the ratio SV/SR. This assumption is justified because S is the major component of I and because the reduction in synthesis after vanadium so calculated is always less than might be expected from direct isotopic measurements of synthesis depression in animal and human tissues in in vivo experiments (4, 27) be noted again that the fall in AB is more dramatic, emphasizing the influence of the relatively labile serum cholesterol. However, the lesser decrease in AT is progressive and the decline from Week 2 to Week 6 is statistically significant at the < 0.05 level.
London and Rittenberg, using D20, calculated the amount of serum cholesterol synthesized per day by a normal young man to be 546 mg. (29 (28) at the end of the recovery period (Table II) ] is roughly four times their mean obtained on patients undergoing surgery. However, allowing for the nutritional differences involved and the fact that they measure only hepatic cholesterol synthesis, our calculated amounts of total body synthesis tend to support Taylor and co-workers' contention that the true human cholesterol synthesis rate may be far lower than currently accepted estimates.
Throughout this study it has been assumed that the effects measured were attributable to the action of vanadium as an inhibitor of cholesterol synthesis alone. While there is no doubt that the major effect of vanadium on lipids is its inhibition of cholesterol synthesis, inhibition of lipogenesis in vitro (3) and of phospholipid synthesis in vitro and in vivo have been reported (25) .
Thus, from the data in this paper it can be reasonably concluded that through inhibition of endogenous cholesterol synthesis by a specific inhibitor of that process it is possible to produce a lowering of tissue cholesterol stores. With specific inhibitors of cholesterol synthesis a practical means is available to test the widely held hypothesis that reduction of body cholesterol content may modify the course of atherosclerosis and, in particular, coronary atherosclerosis. Such tests would require long term studies on large numbers of individuals. The effect of reduction of body cholesterol stores could then be determined from the incidence of myocardial infarction and survival of the treated group. In this manner a definitive answer to the correctness of the original hypothesis can finally be obtained.
1. The effect of a cholesterol synthesis inhibitor (vanadium) on sterol balance in five young men on a fixed diet has been studied.
2. Inhibition of endogenous cholesterol synthesis in man for six weeks resulted in a statistically significant lowering of the serum total and free cholesterol levels and of the C/P ratio. Concomitantly there was a significant reduction in fecal total sterol excretion.
3. A method is presented for the calculation of the dynamics of tissue sterol storage from sterol balance data. By this means it is shown that inhibition of endogenous cholesterol synthesis produced a lowering of tissue cholesterol stores in four of the five men studied.
